Kubes P, Suzuki M, Granger D N
Department of Physiology, Louisiana State Medical Center, Shreveport 71130-3932.
Am J Physiol. 1990 Nov;259(5 Pt 1):G859-64. doi: 10.1152/ajpgi.1990.259.5.G859.
The objective of this study was to assess whether superoxide and leukocyte adhesion glycoproteins (CD18) mediate the leukocyte adherence to mesenteric microvessels and increased intestinal microvascular permeability induced by platelet-activating factor (PAF). PAF was infused into the arterial supply of an isolated autoperfused segment of cat intestine. Thirty minutes into the infusion, the number of adherent leukocytes within mesenteric venules was measured. This was followed by intravenous administration of either human recombinant superoxide dismutase (hSOD), hydrogen peroxide-inactivated hSOD, or a monoclonal antibody against the leukocyte adhesion molecule CD18 (MoAb IB4), and 30 min later, adherence measurements were repeated. hSOD and MoAb IB4 produced a 30 and 66% decrease, respectively, in leukocyte adherence, whereas inactivated hSOD had no effect. Adherence of PAF-activated cat neutrophils to plastic was reduced only by MoAb IB4, suggesting that PAF-induced leukocyte adherence is mediated by both CD18 and superoxide and that endothelium is necessary for the superoxide-mediated adhesion. In a correlate study, hSOD and MoAb IB4 were shown to attenuate the PAF-induced increase in microvascular permeability by 40 and 70%, respectively. These data indicate that the increased microvascular permeability induced by PAF can be attenuated when leukocyte adherence to microvascular endothelium is reduced using molecules that either bind to CD18 adhesive glycoproteins or scavenge superoxide.
本研究的目的是评估超氧化物和白细胞黏附糖蛋白(CD18)是否介导白细胞与肠系膜微血管的黏附以及血小板活化因子(PAF)诱导的肠道微血管通透性增加。将PAF注入猫离体自灌注肠段的动脉供血中。输注30分钟后,测量肠系膜小静脉内黏附白细胞的数量。随后静脉注射人重组超氧化物歧化酶(hSOD)、过氧化氢灭活的hSOD或抗白细胞黏附分子CD18的单克隆抗体(单克隆抗体IB4),30分钟后重复黏附测量。hSOD和单克隆抗体IB4分别使白细胞黏附减少30%和66%,而过氧化氢灭活的hSOD则无作用。仅单克隆抗体IB4可降低PAF激活的猫中性粒细胞对塑料的黏附,这表明PAF诱导的白细胞黏附由CD18和超氧化物介导,且超氧化物介导的黏附需要内皮细胞。在一项相关研究中,hSOD和单克隆抗体IB4分别使PAF诱导的微血管通透性增加降低40%和70%。这些数据表明,当使用与CD18黏附糖蛋白结合或清除超氧化物的分子减少白细胞与微血管内皮的黏附时,PAF诱导的微血管通透性增加可被减弱。